CollPlant Ltd. (TASE:CLPT; OTC:CQPTY), a regenerative medicine company utilizing its proprietary plant-based rhCollagen technology for tissue repair products, today announced positive interim clinical trial results for Vergenix™STR, intended for the treatment of tendinopathy. The 20 patient Vergenix™STR trial, in which